Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M den Heijer

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Journal of Thrombosis and Haemostasis : JTH|January 20, 2006
Are B vitamins a risk factor for VTE? PerhapsM den Heijer
The Netherlands Journal of Medicine|June 26, 2007
Power: not only a matter of numbers, but also of designM den Heijer
Clinical Chemistry and Laboratory Medicine|October 11, 2001
Hyperhomocysteinemia as a risk factor for venous thrombosisM den Heijer, M B Keijzer
The Netherlands Journal of Medicine|June 1, 2013
Established and forthcoming drugs for the treatment of osteoporosisW F Lems, M den Heijer
Seminars in Thrombosis and Hemostasis|October 8, 1998
Hyperhomocysteinemia and venous thrombosisG M Bos, M den Heijer
Journal of Thrombosis and Haemostasis : JTH|January 27, 2005
Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studiesM Den Heijer, S Lewington, R Clarke
Lancet (London, England)|November 15, 2000
Chlamydia pneumoniae IgG seropositivity in deep-vein thrombosisB Maraha, M den Heijer, M Peeters
The Netherlands Journal of Medicine|April 27, 2000
Thrombosis prophylaxis in hospitalised medical patients: does prophylaxis in all patients make sense?B Schuurman, M den Heijer, A M Nijs
Seminars in Thrombosis and Hemostasis|September 30, 2000
Homocysteine and venous thrombosis: outline of a vitamin intervention trialH P Willems, M den Heijer, G M Bos
Journal of Parkinson'S Disease|March 8, 2024
Reply to the Letter to the Editor: Stefani A, "Is it too early to Underrate Genetic onto PD Pathogenesis? Reflections on History"Jolien S Bogers, Bastiaan R Bloem, Jonas M den Heijer
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Journal of Thrombosis and Haemostasis : JTH|January 20, 2006
Are B vitamins a risk factor for VTE? PerhapsM den Heijer
The Netherlands Journal of Medicine|June 26, 2007
Power: not only a matter of numbers, but also of designM den Heijer
Clinical Chemistry and Laboratory Medicine|October 11, 2001
Hyperhomocysteinemia as a risk factor for venous thrombosisM den Heijer, M B Keijzer
The Netherlands Journal of Medicine|June 1, 2013
Established and forthcoming drugs for the treatment of osteoporosisW F Lems, M den Heijer
Seminars in Thrombosis and Hemostasis|October 8, 1998
Hyperhomocysteinemia and venous thrombosisG M Bos, M den Heijer
Journal of Thrombosis and Haemostasis : JTH|January 27, 2005
Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studiesM Den Heijer, S Lewington, R Clarke
Lancet (London, England)|November 15, 2000
Chlamydia pneumoniae IgG seropositivity in deep-vein thrombosisB Maraha, M den Heijer, M Peeters
The Netherlands Journal of Medicine|April 27, 2000
Thrombosis prophylaxis in hospitalised medical patients: does prophylaxis in all patients make sense?B Schuurman, M den Heijer, A M Nijs
Seminars in Thrombosis and Hemostasis|September 30, 2000
Homocysteine and venous thrombosis: outline of a vitamin intervention trialH P Willems, M den Heijer, G M Bos
Journal of Parkinson'S Disease|March 8, 2024
Reply to the Letter to the Editor: Stefani A, "Is it too early to Underrate Genetic onto PD Pathogenesis? Reflections on History"Jolien S Bogers, Bastiaan R Bloem, Jonas M den Heijer
Pageof 13